Psychedelics to treat schizophrenia
Schizophrenia is a chronic brain condition that affects less than 1% of the population. Symptoms of schizophrenia include delusions, hallucinations, disorganized speech, difficulty concentrating, and a loss of motivation. Most symptoms of schizophrenia can be significantly improved with treatment, and the chance of recurrence can be reduced.
Despite the fact that there is no cure for schizophrenia, progress is leading to new and safer therapies. Experts are now researching genetics, conducting behavioral experiments, and using advanced imaging to examine the structure and function of the brain to figure out what causes the disease. These methods hold the promise of developing new and more successful treatments.
The disease’s complexity may explain why there are so many misconceptions about it. Schizophrenia does not imply multiple personalities or split personalities. The majority of people with schizophrenia are no more dangerous or aggressive than the general public. Although a lack of community mental health services may result in homelessness and repeated hospitalizations, it is a common misconception that people with schizophrenia end up homeless or in hospitals. The majority of people with schizophrenia live with their families, in group homes, or alone.
It might sound crazy, but there is an increasing number of clues, that low doses of psychedelics may be used to treat schizophrenia. The majority of evidence is anecdotal or from the 1950s, but some believe, there is just enough to investigate.
It does not mean that all psychedelic doses are safe for people with schizophrenia: these drugs may exacerbate schizophrenia symptoms and cause people to lose grip on reality.
However, one man has anecdotally confirmed that microdoses of cannabis, psilocybin, DMT, and LSD were beneficial in treating his schizophrenia.